DFTX — Definium Therapeutics, Inc.

DFTXDefinium Therapeutics, Inc.

NAS · US · Healthcare · Biotechnology · definiumtx.com

24.44USD+1.75%Mkt Cap: 2.67B USDP/E: —Last update: 2026-06-01

Definium Therapeutics, Inc., a clinical biopharmaceutical company, develops novel product candidates to treat brain health disorders. The company's lead product candidates DT120, which is in phase 3 for the treatment of …

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

40.10BUSDP/E 75.3

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap2.67B USD

Enterprise Value2.31B USD

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-183.79M USD

Revenue/Share—

Last Price24.44 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees105

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-15.30

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B7.19

EPS (TTM)-2.50

EPS (Forward)-1.58

52W Range

6.34591% of range26.25

52W High26.25 USD

52W Low6.345 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-55.30%

ROA-41.76%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-131.56M USD

CapEx (TTM)—

FCF Margin—

FCF Yield-1.71%

Net Debt-332.65M USD

Net Debt/EBITDA—

Balance Sheet

Debt/Equity0.12

Current Ratio4.69

Quick Ratio4.60

Book Value/Sh3.364 USD

Cash/Share3.424 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:15

Split DateAug 29, 2022

Analyst Consensus

Rating1.3 (Strong Buy)

Target (Mean)39.47 USD

Target Range25.00 USD – 70.00 USD

# Analysts15

Ownership

Shares Out.109.07M

Float108.17M

Insiders0.95%

Institutions74.48%

Short Interest

Short Ratio5.0d

Short % Float8.55%

Short % Out.8.48%

Shares Short9.25M

Short (prev mo.)9.82M

Technical

SMA 5021.17 (+15.5%)

SMA 20015.22 (+60.6%)

Beta2.38

S&P 52W Chg27.94%

Avg Vol (30d)1.73M

Avg Vol (10d)1.67M

Technical Indicators

RSI (14)62.5

MACD0.4963

MACD Signal0.2912

MACD Hist.+0.2050

BB Upper24.25 USD

BB Middle22.07 USD

BB Lower19.89 USD

BB Width19.74%

ATR (14)1.157 USD

Vol Ratio (20d)0.90x